Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community

References

• Alberti KG, Zimmet PZ, for the WHO Consultation Group. Definition, diagnosis and classification of diabetes and its complication. Diabet Med 1998;15:539–53.
   PubMed Web of Science ®Google Scholar
• Zimmet PZ. Kelly West Lecture 1991. Challenges in diabetes epidemiology: From the west to the rest. Diabet Care 1992; 15: 232–52
   PubMed Web of Science ®Google Scholar
• Stern MP. The insulin resistance syndrome. International textbook of diabetes mellitus2nd edn, KGMM Alberti, PZ Zimmet, RA DeFronzo. Wiley, Chichester 1997; 255–83
   Google Scholar
• Groop L. Genetics of the metabolic syndrome. Br J Nutr 2000; 83: 39–48
   Google Scholar
• Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiological Rev 1994; 74: 761–811
   PubMed Web of Science ®Google Scholar
• Snehalatha C, Sivasankari S, Satyavani K, Vijay V, Ramachandran A. Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India. Diabet Med 2000; 17: 152–7
   PubMed Web of Science ®Google Scholar
• Ho SC, Chen YM, Woo JL, Leung SS, Lam TH, Janus ED. Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes Relat Metab Disord 2001; 25: 1689–97
   PubMed Web of Science ®Google Scholar
• Daniel M, Marion SA, Sheps SB, Hertzman C, Gamble D. Variation by body mass index and age in waist-to-hip ratio associations with glycemic status in an aboriginal population at risk for type 2 diabetes in British Columbia, Canada. Am J Clin Nutr 1999; 69: 455–60
   PubMed Web of Science ®Google Scholar
• Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med 2003; 14: 101–6
   PubMedGoogle Scholar
• Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961–9
   PubMed Web of Science ®Google Scholar
• Ostgren CJ, Lindblad U, Bog-Hansen E, Ranstam J, Melander A, Rastam L. Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: The Skaraborg Hypertension and Diabetes Project. Diabet Obes Metab 1999; 1: 105–12
   PubMed Web of Science ®Google Scholar
• Bog–Hansen E, Merlo J, Gullberg B, Melander A, Rastam L, Lindblad U. Survival in patients with hypertension treated in primary care: A population-based follow-up study in the Skaraborg Hypertension and Diabetes Project. Scand J Prim Health Care 2004; 22: 222–7
   PubMed Web of Science ®Google Scholar
• Spooren PF, Lekkerkerker JF, Vermes I. Micral-Test: A qualitative dipstick test for microalbuminuria. Diabetes Res Clin Pract 1992; 18: 83–7
   PubMedGoogle Scholar
• Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578–82
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–19
   PubMed Web of Science ®Google Scholar
• Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment Panel III). JAMA 2001;285:2486–97.
   PubMed Web of Science ®Google Scholar
• Rastam L, Sjonell G. A new device for measuring blood pressure in adults. Lancet 1991; 337: 249–50
   PubMed Web of Science ®Google Scholar
• National Board of Health and Welfare Drug Information Committee. Treatment of mild hypertension. Stockholm; 1987.
   Google Scholar
• World Health Organization Expert Committee. Diabetes mellitus: Technical Report. Geneva: WHO; 1985. p 742.
   Google Scholar
• Haffner S, Miettinen H, Stern M. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997; 20: 1087–92
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2002; 25: 626–40
   Google Scholar
• Colditz G, Willett W, Rotnitzky A, Manson J. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481–6
   PubMed Web of Science ®Google Scholar
• Valsamakis G, Chetty R, Anwart A, Banarjee K, Barnett A, Kumar S. Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects. Diabet Med 2004; 21: 1339–45
   PubMed Web of Science ®Google Scholar
• Despres JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993; 9: 452–9
   PubMed Web of Science ®Google Scholar
• Ezenwaka CE, Offiah NV. Abdominal obesity in type 2 diabetic patients visiting primary healthcare clinics in Trinidad, West Indies. Scand J Prim Health Care 2002; 20: 177–82
   PubMed Web of Science ®Google Scholar
• Lindblad U, Langer RD, Wingard DL, Thomas RG, Barrett-Connor EL. Metabolic syndrome and ischemic heart disease in elderly men and women. Am J Epidemiol 2001; 153: 481–9
   PubMedGoogle Scholar
• Groop LC. The etiology of non-insulin-dependent diabetes mellitus. In: Leskie RDG, editor. Molecular pathogenesis of diabetes mellitus. Front Horm Res 22, 131–56. Basel: Karger; 1997.
   Google Scholar
• Tuomi T, Groop L, Zimmet PZ, Rowley MJ, Knowles W, Mackay R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42: 359–62
   PubMed Web of Science ®Google Scholar
• Hansen LJ, Olivarius Nde F, Siersma V, Drivsholm T, Andersen JS. Individualised treatment goals in diabetes care. Scand J Prim Health Care 2004; 22: 71–7
   PubMed Web of Science ®Google Scholar
• Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A randomised controlled trial. Lancet 2005; 366: 1279–89
   PubMed Web of Science ®Google Scholar